Palewater
Palewater runs the unglamorous half of a clinical trial: scheduling, consent, and the paperwork that decides whether a site stays open.
What we saw in Palewater.
Trials do not usually fail on the science. They fail because a site cannot recruit, cannot keep coordinators, or cannot produce documentation an auditor will accept.
Ana ran three sites as a principal investigator and built the first version for her own team. When we met her, eleven other sites were already using it without any sales effort.
Health takes patience. We modelled a five-year path to meaningful revenue and Palewater beat it, which is not something we assume.
The company in short.
- Founded
- 2020, Boston
- Founders
- Dr Ana Whitfield
- Sector
- Health
- First cheque
- Seed, 2021
- Our role
- Led the seed, board observer
- Partner
- Priya Ramanathan
- Status
- Active
- Website
- palewater.health
How Palewater has moved.
Built inside a Boston research hospital for one oncology programme.
Rifatela led the $3.5M seed.
Used by 210 trial sites across North America and the UK.
“Priya read our clinical validation protocol line by line and sent back questions our own advisers had missed. That was before she invested.”
Dr Ana Whitfield, founder and CEO, Palewater
Companies working on nearby problems.
Building something in this space?
We back one or two companies a year in each sector. If that is you, send us a short note.